DOC scholarships from the Austrian Academy of Sciences (ÖAW) for young scientists at the Vetmeduni Vienna.

Myint Aung (group Heidi Neubauer) and Jonatan Kendler (group Richard Moriggl) were each awarded one of the coveted DOC scholarships of the Austrian Academy of Sciences (ÖAW, https://stipendien.oeaw.ac.at/en/fellowships/doc). The scholarships are awarded to outstanding young scientists in a highly competitive selection process.

Myint will use preclinical mouse modelst o investigate the oncogenic STAT5B-driven disease mechanisms and druggabilities in γδ T cell lymphoma.

Jonatan aims to unravel the interplay of CDK6 and STAT5B in NPM/ALK-driven haematopoietic malignancies to define therapeutic vulanerabilities. Both scholarships will start in 2024.

The SFB members congratulate!

oaw scholarship 2

Sylvia Knapp receives Prize of the City of Vienna

On 16 May 2023 Sylvia Knapp, Professor of Infection Biology at the Medical University of Vienna and PI of SFB F61, was awarded the Prize of the City of Vienna in the category Medical Sciences. The awards for outstanding achievements in culture and science were presented by the City Councillor for Culture and Science, Veronica Kaup-Hasler, in a festive ceremony in the ballroom of Vienna City Hall.

For further information see:

https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-may-2023/sylvia-knapp-erhaelt-preis-der-stadt-wien/

https://presse.wien.gv.at/2022/12/09/preise-der-stadt-wien-2022-fuer-herausragende-leistungen-in-kultur-und-wissenschaft

The SFB members Anna Orlova and Richard Moriggl are co-founders of the pharmaceutical start-up RIANA Therapeutics spun out of Vetmeduni Vienna in February 2023. RIANA Therapeutics focuses on developing novel anti-cancer treatments with hope to improve life of cancer patients.

For further information see https://www.vetmeduni.ac.at/en/universitaet/infoservice/presseinformationen/presseinformationen-2023/riana-viennese-start-up-develops-novel-precise-anti-cancer-drugs

Foto credit Thomas Suchanek/Vetmeduni Vienna

The SFB Jak-Stat subproject leader Veronika Sexl took the lead of the University of Innsbruck (https://www.uibk.ac.at/en/) in March 2023. Veronika was appointed head of the rectorate in an international selection process for a period of four years. The SFB members congratulate Veronika to this highly responsible and prestigious position. We will miss Veronika’s scientific excellence and spirit in our team and wish her a successful and fruitful time in Innsbruck.

Richard Moriggl – a long-term member of the SFB – will take over the leadership of the subproject ‘Partners in Crime: STAT3 and CDK6 Control Transformation in Hematopoietic Cells’. We highly appreciate the commitment of Richard and look forward to exciting interactions.

Foto credit Michael Bernkopf/Vetmeduni Vienna

Interferons (IFNs) activate cell-intrinsic defence mechanisms to fight infections. The innate immune response to infections overlaps and cooperates with cellular stress signalling governed by the mitogen-activated protein kinase (MAPK) p38. Laura Boccuni in the group of Thomas Decker unravelled the molecular mechanism how macrophages merge the IFN JAK-STAT and the stress p38 MAPK pathways to enhance the beneficial but also the detrimental effects of the innate and inflammatory responses. With the exception of one, all SFB groups contributed to this SFB-financed publication.

Published in Science Signaling

Laura Boccuni, Elke Podgorschek, Moritz Schmiedeberg, Ekaterini Platanitis, Peter Traxler, Philipp Fischer, Alessia Schirripa, Philipp Novoszel, Angel R. Nebreda, J. Simon C. Arthur, Nikolaus Fortelny, Matthias Farlik, Veronika Sexl, Christoph Bock, Maria Sibilia, Pavel Kovarik, Mathias Müller, Thomas Decker

Stress signaling boosts interferon-induced gene transcription in macrophages
https://doi.org/10.1126/scisignal.abq5389

See also for RELATED FOCUS: Rewiring the logic board of IFN signaling, by John D. MacMicking John D. MacMicking
https://doi.org/10.1126/scisignal.adf0778

The JAK-STAT signaling pioneers James E Darnell, John J O‘Shea and George R Stark and former or current co-workers in their labs co-author a comprehensive review on the current knowledge on the cellular and systemic activities of JAKs and STATs and possibilities of their therapeutic targeting in disease settings (see https://doi.org/10.1016/j.cell.2022.09.023).

The Viennese JAK-STAT community congratulates this fascinating pathway to its 30ies anniversary!

Clemens Schmitt

Tuesday November 15th 2022, 13.30 

Clemens Schmitt

Kepler Universitätsklinikum / Johannes Kepler Universität Linz

Hämatologie und Internistische Onkologie (https://www.kepleruniklinikum.at/kliniken-einrichtungen/innere-medizin-3-haematologie-und-internistische-onkologie/team).

Title: Not just arrested – senescence-associated plasticity in cancer

Host: Veronika Sexl

Location: Vetmeduni Vienna Bldg NA, Room 07 B00 & Hybrid Blackboard Collaborate (https://eu.bbcollab.com/guest/eb6707f5a10e49b6b89f9d48d07a5cc5)

 

Matthias Ernst

Wednesday June 8th 2022, 10 am 

Matthias Ernst

Director, ONJCRI
Head Cancer and Inflammation Program and Laborartory
Head School of Cancer Medicine, La Trobe University (https://www.onjcri.org.au/about-us/matthias-ernst/).

Title: Targeting IL-11 to prevent oncogenic STAT3 signaling and Src kinase as regulator of myeloid cell proliferation

Host: Richard Moriggl

Location: Vetmeduni Vienna Bldg NA, Room 07 B00 & Hybrid Blackboard Collaborate (https://eu.bbcollab.com/guest/9ebec0a0bcf448e2a1dec957827b18ca)